GlaxoSmithKline
GSK
#208
Rank
NZ$170.01 B
Marketcap
NZ$84.23
Share price
-0.82%
Change (1 day)
48.28%
Change (1 year)

GlaxoSmithKline (GSK) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$41.37 Billion

According to GlaxoSmithKline's latest financial reports the company's total debt is NZ$41.37 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

GlaxoSmithKline - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$37.79 B4.13%
2023-12-31NZ$36.29 B-9.23%
2022-12-31NZ$39.99 B-16.29%
2021-12-31NZ$47.77 B-6.86%
2020-12-31NZ$51.28 B-13.66%
2019-12-31NZ$59.40 B20.43%
2018-12-31NZ$49.32 B51.67%
2017-12-31NZ$32.52 B-2.84%
2016-12-31NZ$33.47 B-7.06%
2015-12-31NZ$36.01 B-3.52%
2014-12-31NZ$37.32 B1.92%
2013-12-31NZ$36.62 B1.85%
2012-12-31NZ$35.95 B21.17%
2011-12-31NZ$29.67 B-1.78%
2010-12-31NZ$30.21 B-16.58%
2009-12-31NZ$36.21 B-11.4%
2008-12-31NZ$40.88 B48.96%
2007-12-31NZ$27.44 B79.86%
2006-12-31NZ$15.25 B-17.88%
2005-12-31NZ$18.58 B15.87%
2004-12-31NZ$16.03 B14.35%
2003-12-31NZ$14.02 B-1.42%
2002-12-31NZ$14.22 B-3.95%
2001-12-31NZ$14.80 B9.06%
2000-12-31NZ$13.57 B25.13%
1999-12-31NZ$10.85 B10.21%
1998-12-31NZ$9.84 B15.11%
1997-12-31NZ$8.55 B8.77%
1996-12-31NZ$7.86 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
AstraZeneca
AZN
NZ$56.58 B 36.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$105.51 B 155.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$71.74 B 73.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$55.52 B 34.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$44.27 B 7.00%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
NZ$29.60 B-28.45%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
NZ$0.49 B-98.81%๐Ÿ‡บ๐Ÿ‡ธ USA